Development of a T-cell activation-related module with predictive value for the prognosis and immune checkpoint blockade therapy response in glioblastoma.

Yan, Zihao; Chu, Siwen; Zhu, Chen; Han, Yunhe; Liang, Qingyu; Shen, Shuai; Cheng, Wen; Wu, Anhua

Yan, Zihao; Chu, Siwen; Zhu, Chen; Han, Yunhe; Liang, Qingyu; Shen, Shuai; Cheng, Wen; Wu, Anhua.

Afiliación

Yan Z; Department of Neurosurgery, The First Hospital of China Medical University, Shenyang, Liaoning, China.
Chu S; Department of Ultrasound, The First Hospital of China Medical University, Shenyang, Liaoning, China.
Zhu C; Department of Neurosurgery, The First Hospital of China Medical University, Shenyang, Liaoning, China.
Han Y; Department of Neurosurgery, The First Hospital of China Medical University, Shenyang, Liaoning, China.
Liang Q; Department of Neurosurgery, The First Hospital of China Medical University, Shenyang, Liaoning, China.
Shen S; Department of Neurosurgery, The First Hospital of China Medical University, Shenyang, Liaoning, China.
Cheng W; Department of Neurosurgery, The First Hospital of China Medical University, Shenyang, Liaoning, China.
Wu A; Department of Neurosurgery, The First Hospital of China Medical University, Shenyang, Liaoning, China.

PeerJ ; 9: e12547, 2021.

Article en En | MEDLINE | ID: mdl-35036121

Palabras clave

Glioblastoma; Immune checkpoint blockade; Immunotherapy; T-cell activation; Tumor microenvironment

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: PeerJ Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google